Further identification of CTX-M-2 extended-spectrum β-lactamase in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2225-2226

  Picão, Renata Cristina ^a   Poirel, Laurent ^a   Gales, Ana C ^b   Nordmann, Patrice ^c  

^a BICÊTRE HOSPITAL   (France)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE CTX M 2; GENTAMICIN; IMIPENEM; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN; TOBRAMYCIN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ADULT; BRAZIL; CASE REPORT; ENZYME ACTIVITY; ENZYME ANALYSIS; EPSILOMETER TEST; FATALITY; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK;

EID: 66149102344     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01602-08     Document Type: Letter

References (9)

1. Al Naiemi, N., B. Duim, and A. Bart. 2006. A CTX-M extended-spectrum β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Med. Microbiol. 55:1607-1608.
2. PER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J. Antimicrob. Chemother. 57:975-978.
3. Gales, A. C., L. C. Menezes, S. Silbert, and H. S. Sader. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J. Antimicrob. Chemother. 52:699-702.
4. Kieser, T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. (Pubitemid 14046088)
5. Pitout, J. D., and K. B. Laupland. 2008. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
6. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632. (Pubitemid 30117952)
7. Poirel, L., T. Naas, and P. Nordmann. 2008. Genetic support of extended-spectrum β-lactamases. Clin. Microbiol. Infect. 14:75-81. (Pubitemid 350269188)
8. Walsh, T. R. 2008. Clinically significant carbapenemases: an update. Curr. Opin. Infect. Dis. 21:367-371.
9. Weldhagen, G. F., L. Poirel, and P. Nordmann. 2003. Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392.